ABC
AGIO icon

Associated Banc-Corp’s Agios Pharmaceuticals AGIO Stock Holding History

Associated Banc-Corp’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-61
Closed -$3K – 296
2020
Q4 		$3K Buy
61
+60
+6,000% +$2.37K ﹤0.01% 597
2020
Q3 		$0 Sell
1
-47
-98% -$2.06K ﹤0.01% 987
2020
Q2 		$3K Buy
48
+4
+9% +$185 ﹤0.01% 483
2020
Q1 		$2K Buy
+44
New +$2.03K ﹤0.01% 509

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Associated Banc-Corp's AGIO Position: Q1 2021 in Review

Associated Banc-Corp sold out of Agios Pharmaceuticals (AGIO) in Q1 2021, closing a stake of 61 shares — an estimated $3K sold.

Associated Banc-Corp first reported a position in AGIO in Q1 2020 and held it in 4 quarters. The position peaked at $3K in Q4 2020. 174 funds tracked by Wall St. Rank hold AGIO as of Q1 2021.

  • Associated Banc-Corp reported no remaining Agios Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 61 Agios Pharmaceuticals shares in Q1 2021, an estimated $3K.
  • Associated Banc-Corp first reported a position in Agios Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Agios Pharmaceuticals position peaked at $3K in Q4 2020.
  • 174 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.